Company Directory / research
PrivateFor profitresearchLondon, United Kingdom
LOQUS23 THERAPEUTICS
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
- Founded
- 2019 7 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $46M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
7 years old.
Reach
No web traffic ranking listed.
What it does
Biotechnology
Funding, as listed
$46M currency not stated
- Rounds3
- LatestSeed, Nov 2021
- Investors3, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about LOQUS23 THERAPEUTICS, field by field. Contact details are held but never shown.
The company
- Name
- LOQUS23 THERAPEUTICS
- Type
- For profit
- Status
- Private
- Founded
- 2019
- Founders
- David Reynolds
- Industry
- research
- Categories
- Biotechnology
Where
- City
- London
- Country
- United Kingdom
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 1-10
Funding, as listed
- Total
- 46,420,022 (currency not stated)
- Rounds
- 3
- Latest round
- Seed
- Latest round date
- Nov 2021
- Investors
- 3
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.